Synthesis of novel benzimidazole–oxadiazole derivatives as potent anticancer activity

DNA topoisomerase I regulates DNA topological structure in many cellular metabolic processes and is a validated target for the development of antitumor agents. In this work, a series of novel 2-[(5-(4-(5(6)-substituted-1 H -benzimidazol-2-yl)phenyl)-1,3,4-oxadiazol-2-yl)thio]-1-(4-substitutedphenyl)...

Full description

Saved in:
Bibliographic Details
Published inMedicinal chemistry research Vol. 28; no. 12; pp. 2252 - 2261
Main Authors Çevik, Ulviye Acar, Osmaniye, Derya, Çavuşoğlu, Betül Kaya, Sağlik, Begüm Nurpelin, Levent, Serkan, Ilgin, Sinem, Can, Nafiz Öncü, Özkay, Yusuf, Kaplancikli, Zafer Asım
Format Journal Article
LanguageEnglish
Published New York Springer US 01.12.2019
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:DNA topoisomerase I regulates DNA topological structure in many cellular metabolic processes and is a validated target for the development of antitumor agents. In this work, a series of novel 2-[(5-(4-(5(6)-substituted-1 H -benzimidazol-2-yl)phenyl)-1,3,4-oxadiazol-2-yl)thio]-1-(4-substitutedphenyl)ethan-1-ones ( 4a–4s ) derivatives have been synthesized and evaluated for DNA Topo I inhibition and cytotoxicity. The structures of the compounds ( 4a–4s ) were confirmed by IR, 1 H-NMR, 13 C-NMR, 2D NMR, and mass spectroscopy. Anticancer activity of these compounds was assessed against two different human cancer cell lines A549 (human lung adenocarcinoma) and HepG2 (human liver cancer cell line), as well as normal mouse embryonic fibroblast cells (NIH3T3). IC 50 values of compounds 4a , 4c , and 4 f were highest than those exhibited for the reference drug cisplatin. Then, the inhibitory effect of 4a , 4c , and 4 f compounds on topoisomerase I enzyme with the relaxation assay was investigated on supercoiled DNA using agarose gel electrophoresis. The Annexin V-FITC assay demonstrated that these compounds induce cell death by apoptosis.
ISSN:1054-2523
1554-8120
DOI:10.1007/s00044-019-02451-0